MYBL2 has been identified as a direct target of EWSR1::FLI1 with germline polymorphisms associated with activation in Ewing sarcoma and RRM2 overexpression is associated with poor prognosis Ewing sarcoma (36, 37). This evidence concerns the gene MYBL2 and Ewing sarcoma.